Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 50 percent decrease over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $30.971 million which beat the analyst consensus estimate of $29.007 million by 6.77 percent. This is a 59.88 percent increase over sales of $19.371 million the same period last year.